|
🐜
|
A Randomized Trial Comparing Postoperative Adjuvant Chemotherapy with Cisplatin and 5-Fluorouracil Versus Preoperative Chemotherapy for Localized Advanced Squamous Cell Carcinoma of the Thoracic Esophagus (JCOG9907)
15 auth.
N. Ando,
H. Kato,
H. Igaki,
M. Shinoda,
S. Ozawa,
H. Shimizu,
Tsutomu Nakamura,
H. Yabusaki,
N. Aoyama,
A. Kurita,
...
K. Ikeda,
T. Kanda,
T. Tsujinaka,
Kenichi Nakamura,
H. Fukuda
|
10 |
2011 |
10
🐜
|
|
🐜
|
Three-arm phase III trial comparing cisplatin plus 5-FU (CF) versus docetaxel, cisplatin plus 5-FU (DCF) versus radiotherapy with CF (CF-RT) as preoperative therapy for locally advanced esophageal cancer (JCOG1109, NExT study).
12 auth.
Kenichi Nakamura,
Ken Kato,
H. Igaki,
Yoshinori Ito,
J. Mizusawa,
N. Ando,
...
H. Udagawa,
Y. Tsubosa,
H. Daiko,
S. Hironaka,
H. Fukuda,
Y. Kitagawa
|
8 |
2013 |
8
🐜
|
|
🐜
|
Histopathological criteria for additional treatment after endoscopic mucosal resection for esophageal cancer: analysis of 464 surgically resected cases
10 auth.
T. Eguchi,
Y. Nakanishi,
T. Shimoda,
M. Iwasaki,
H. Igaki,
Y. Tachimori,
...
H. Kato,
H. Yamaguchi,
D. Saito,
S. Umemura
|
8 |
2006 |
8
🐜
|
|
🐜
|
Genetic polymorphisms of alcohol and aldehyde dehydrogenases and glutathione S-transferase M1 and drinking, smoking, and diet in Japanese men with esophageal squamous cell carcinoma.
13 auth.
A. Yokoyama,
H. Kato,
T. Yokoyama,
T. Tsujinaka,
M. Muto,
T. Omori,
T. Haneda,
Y. Kumagai,
H. Igaki,
Masako Yokoyama,
...
Hiroshi Watanabe,
H. Fukuda,
Haruko Yoshimizu
|
7 |
2002 |
7
🐜
|
|
🐬
|
Salvage esophagectomy after high-dose chemoradiotherapy for esophageal squamous cell carcinoma.
Y. Tachimori,
N. Kanamori,
N. Uemura,
N. Hokamura,
H. Igaki,
H. Kato
|
7 |
2009 |
7
🐬
|
|
🐜
|
Alcohol flushing, alcohol and aldehyde dehydrogenase genotypes, and risk for esophageal squamous cell carcinoma in Japanese men.
12 auth.
T. Yokoyama,
A. Yokoyama,
H. Kato,
T. Tsujinaka,
M. Muto,
T. Omori,
...
T. Haneda,
Y. Kumagai,
H. Igaki,
Masako Yokoyama,
Hiroshi Watanabe,
Haruko Yoshimizu
|
7 |
2003 |
7
🐜
|
|
🐜
|
Phase II feasibility study of preoperative chemotherapy with docetaxel, cisplatin, and fluorouracil for esophageal squamous cell carcinoma
11 auth.
H. Hara,
M. Tahara,
H. Daiko,
Ken Kato,
H. Igaki,
S. Kadowaki,
...
Yoichi Tanaka,
Y. Hamamoto,
H. Matsushita,
M. Nagase,
Y. Hosoya
|
7 |
2013 |
7
🐜
|
|
🐜
|
Prognostic Impact of Postoperative Morbidity After Esophagectomy for Esophageal Cancer: Exploratory Analysis of JCOG9907
10 auth.
K. Kataoka,
H. Takeuchi,
J. Mizusawa,
H. Igaki,
S. Ozawa,
T. Abe,
...
Kenichi Nakamura,
Ken Kato,
N. Ando,
Y. Kitagawa
|
7 |
2017 |
7
🐜
|
|
🐜
|
Frequent and preferential infection of Treponema denticola, Streptococcus mitis, and Streptococcus anginosus in esophageal cancers
11 auth.
M. Narikiyo,
C. Tanabe,
Yukishige Yamada,
H. Igaki,
Y. Tachimori,
H. Kato,
...
M. Muto,
R. Montesano,
H. Sakamoto,
Y. Nakajima,
H. Sasaki
|
7 |
2004 |
7
🐜
|
|
🐜
|
Genetic polymorphisms of alcohol and aldehyde dehydrogenases, and drinking, smoking and diet in Japanese men with oral and pharyngeal squamous cell carcinoma.
13 auth.
T. Asakage,
A. Yokoyama,
T. Haneda,
Mitsuo Yamazaki,
M. Muto,
T. Yokoyama,
H. Kato,
H. Igaki,
T. Tsujinaka,
Y. Kumagai,
...
Masako Yokoyama,
T. Omori,
Hiroshi Watanabe
|
7 |
2006 |
7
🐜
|
|
🐬
|
Cervical, mediastinal, and abdominal lymph node dissection (three–field dissection) for superficial carcinoma of the thoracic esophagus
H. Kato,
Y. Tachimori,
S. Mizobuchi,
H. Igaki,
Atsushi Ochiai
|
7 |
1993 |
7
🐬
|
